Sources: Haleon is among the bidders for Thorne supplements manufacturer

Haleon, a consumer health company, bid on Thorne U.S. Supplements firm, according to sources. This was done at a moment when Haleon hoped to expand into the approximately $70 billion U.S. Haleon, a consumer health company, bid for Thorne U.S. supplements firm on Friday. This was at a time when Haleon was hoping to expand in the roughly $70 billion?U.S. market.

Thorne is a private equity firm owned by LVMH, L Catterton, that was acquired in 2023 for $680'million. Investment bankers have been exploring a possible sale and have?attracted strategic interests, including a Haleon bid, according to two sources familiar with the situation.

Thorne declined to comment. Thorne is a company that mainly sells dietary supplements in the United States. Haleon's spokesperson, who makes Advil and Centrum vitamin, declined to comment. L Catterton didn't immediately respond to our request for comment.

Unilever, a consumer goods company, was not a bidder for Thorne according to three sources. Unilever's CEO Fernando Fernandez has been focusing on beauty and wellness brands.

Financial Times earlier reported on Friday that Unilever is among the'several bidders' for Thorne, a South Carolina-based company. The FT reported that Thorne could be valued up to $4 billion.

Unilever didn't immediately respond to our request for comment.

Grand View Research estimates the U.S. dietary supplement market to be $68.74 Billion in 2025, and projects that it will reach $131.08 Billion by?2033. (Reporting and editing by Devika?Syamnath and Tomasz?Janowski in New York, Richa Naidu and Abigail Summerville, in London.

(source: Reuters)